INTRODUCTION
An inflammatory microenvironment is an essential component of epithelial tumors that develop on the basis of chronic inflammatory conditions as well as of those malignancies that emerge in an inflammation-independent manner (Quante et al., 2013) . In both instances, recruitment of various types of adaptive and innate immune cells can be observed. Depending on the dominating cell type and polarization profile of the infiltrating cells, tumorigenesis is promoted or suppressed (Grivennikov et al., 2010) . Recently, an immune score relying on the intratumoral localization of cytotoxic and memory T cells was established in colorectal cancer (CRC) (Fridman et al., 2012) . This immune score has a powerful prognostic value and exemplifies the importance of immune cells for this tumor entity. Moreover, a large number of functional in vivo studies have provided substantial evidence demonstrating a key role of myeloid cells in colorectal cancer as well as other tumor entities (Grivennikov et al., 2010) . In analogy to the Th1/Th2 classification of T cells, macrophages have been suggested to be grouped into classically activated M1 (in response to interferon g [IFNg] or microbial products) or alternatively activated M2 macrophages (in response to interleukin 4 [IL-4]; Gordon and Taylor, 2005) In the context of tumor-associated macrophages, M1 macrophages are considered to behave in a tumoricidal manner whereas M2 macrophages promote tumorigenesis (Mantovani et al., 2002) . However, the exact molecular and cellular basis underlying the tumor-promoting lymphocyte and myeloid cell polarization within the tumor microenvironment is still poorly defined.
Nuclear factor (NF)-kB activation leads to the establishment of a protumorigenic inflammatory microenvironment of various malignancies (Bollrath and Greten, 2009) . NF-kB is tightly controlled by the IkB-kinase (IKK) complex, which consists of two catalytic subunits, namely the IKKa and IKKb proteins, as well as the regulatory subunit IKKg (Chariot, 2009 ). The classical NF-kB activation controls key functions for tumor initiation, promotion, and progression both in tumor as well as in infiltrating myeloid cells (Karin and Greten, 2005) . In contrast to classical IKKg/ IKKb-dependent NF-kB signaling, alternative NF-kB activation depends solely on IKKa (Vallabhapurapu and Karin, 2009 ). Moreover, IKKa comprises a nuclear localization signal and can therefore also confer important nuclear functions (Chariot, 2009) . Whereas, in most malignancies, IKKb-dependent NF-kB signaling clearly promotes tumorigenesis, the role of IKKa in this context is more complex. Inhibition of IKKa prolongs survival and suppresses occurrence of metastatic diseases in models of mammary and prostate cancer (Cao et al., 2007; Luo et al., 2007; Tan et al., 2011; Zhang et al., 2013) . In contrast, loss of IKKa enhances susceptibility to carcinogen-induced squamous cell carcinomas (SCC) in the skin and leads to development of spontaneous lung SCC (Liu et al., 2008; Xiao et al., 2013) . Interestingly, the latter depends in part on the development of an excessive inflammatory environment triggered by IKKa mutant macrophages (Xiao et al., 2013) .
Globally sporadic CRC comprises the second most common cause of cancer in women and the third most common cause in men (Jemal et al., 2009) . In over 80% of the cases, it is initiated by APC and CTNNB mutations that cause persistent activation of the Wnt pathway (Fearon, 2011) . We could recently demonstrate that proinflammatory IKKb-dependent NF-kB signaling enhances b-catenin promoter binding, causing dedifferentiation of postmitotic epithelia and tumor stem cell expansion during Wnt-dependent tumor initiation (Schwitalla et al., 2013a) . Moreover, canonical NF-kB activation controls development of epithelial-mesenchymal transition (EMT) and myeloid cell recruitment in Tp53-deficient invasive carcinomas (Schwitalla et al., 2013b) . In contrast, IKKa directly phosphorylates b-catenin, thus increasing its abundance to promote cyclin D1 expression (Albanese et al., 2003) , and in colorectal cancer cells, an active IKKa isoform was described (Margalef et al., 2012) . However, functional genetic evidence supporting a cell autonomous or nonautonomous role of IKKa and/or the alternative NF-kB activation pathway in colorectal carcinogenesis is lacking.
RESULTS

Impaired IKKa Activation Suppresses Intestinal Tumorigenesis
To functionally examine the role of IKKa during early intestinal tumorigenesis, we employed Ikka AA/AA knockin mice, which contain alanines instead of serines in the activation loop of IKKa and express therefore a nonactivatable form of this kinase . Whereas Ikka AA/AA mice are characterized by impaired development of Peyer's patches (Senftleben et al., 2001) (Schwitalla et al., 2013a) . Similarly to the results obtained in AOM-induced and Apc-dependent tumor models, mutant IKKa blocked proliferation and expansion of c-myc-expressing b-catenin mutant crypts within 2 weeks after tamoxifen induction (Figures 2A-2C ). This was associated with decreased CDK1 and CDK2 activity when mice were analyzed 15 days after the first tamoxifen administration ( Figures 2D and 2E ). Accordingly, impaired IKKa activation prolonged survival of b-cat c.a. mutant animals ( Figure 2F ). Interestingly, loss of NF-kB2/p100 did not affect survival, indicating that IKKa acted independently of the alternative NF-kB activation pathway (Hayden and Ghosh, 2004) . In line with this notion, we also did not observe any differences in p100 processing in b-cat c.a. /Ikka AA/AA IEC (data not shown). Figure S1 ). Therefore, we focused our attention on the group of transcripts that were markedly upregulated in IEC from b-cat c.a.
/Ikka
AA/AA mice. These could be classified into genes associated with immune response and inflammatory functions when sorted by their membership in KEGG pathways ( Figure 3A ). More specifically, gene set enrichment analysis (GSEA) indicated an enrichment 
/ Ikka
AA/AA mice ( Figure 3D ). Moreover, immunoblot analysis confirmed activation of tyrosine-phosphorylated Stat1(Y701) as well as upregulation of Nos2 and IRF-1 in IKKa mutant IEC ( Figure 3E ). Because IFNg/Stat1 signaling is known to suppress tumor cell proliferation, this raised the possibility that the decreased IEC proliferation in b-cat c.a.
/Ikka
AA/AA mice was non-cell-autonomous and IFNg dependent. To confirm this hypothesis, we either adoptively transferred Ikka AA/AA bone marrow to b-cat c.a. mice or used conditional Ikka 
AA/AA mice when animals were analyzed 15 days after the first tamoxifen administration ( Figure 5B ). Moreover, when we differentiated naive T cells by log rank test. See also Figure S1 .
from either wild-type or Ikka AA/AA animals into either Th 1 or Th 2 cells ex vivo, we were not able to determine any significant changes between the two genotypes ( Figure S2A ). Consequently, athymic nude mice (NU-Foxn1 nu ) that lack T cells did not revert the survival advantage of b-cat c.a.
AA/AA mice (data not shown). In addition, also depletion of NK cells using a-asialo-GM-1 antibody (reduction of >90% of splenic DX5 During carcinogenesis, polarization of myeloid cells into M1 or M2 macrophages or in the case of neutrophils into N1 or N2 has been suggested to play an important role for tumor development (Sica and Mantovani, 2012) . Depending on the prevailing polarization profile, M1 macrophages (typically expressing Ifng, Tnfa, Il12, Nos2, Cxcl9, Cxcl10, and Cxcl11) are considered tumoricidal, whereas M2 macrophages (characterized by high levels of Arg1, Mrc1, Ccl17, Ccl22, Ym1, and Fizz1) have been suggested to promote tumorigenesis (Sica and Mantovani, 2012) . Considering the lack of T and NK cell involvement in the pronounced expression of Nos2 and Ifng, we speculated that instead a general shift in macrophage polarization toward M1 could have been 
/ Ikka
AA/AA mice 15 days after the first tamoxifen application.
responsible for this. Indeed, besides Nos2 and Ifng, expression of several other genes encoding M1 markers were elevated in the lamina propria of b-cat c.a. /Ikka AA/AA mice 15 days after the first tamoxifen administration, whereas only Ccl17 among M2-associated genes was downregulated ( Figure 6A ). To examine whether Ikka AA/AA mutant macrophages per se would reveal an M1 phenotype, we stimulated bone-marrow-derived macrophages (BMDM) under M1-or M2-polarizing conditions. Interestingly, ex vivo Ikka AA/AA macrophages did not reveal an enhanced M1 polarization profile compared to control BMDM and did not show a preferred polarization ( Figure 6B ). Moreover, also Ifng expression was indifferent when BMDM of either genotype were stimulated with a combination of IL-12 and IL-18 ( Figure S2C ), thus ruling out a cell autonomous regulation in the generation of Ikka AA/AA M1-like cells in vivo.
Elevated expression levels of myeloid-recruiting chemokines such as Cxcl1, Cxcl2, Cxcl5, and Ccl2 ( Figure 6C ) led to enhanced recruitment of macrophages, neutrophils, and dendritic cells into the lamina propria of b-cat c.a.
/Ikka
AA/AA mutants, as determined by real-time PCR of genes encoding surface markers Emr1, Ly6g, and Itgax ( Figure 6D Figures 7B-7E ). We recently demonstrated that loss of RelA/p65 expanded the life span of b-cat c.a. mice (Schwitalla et al., 2013a) . Similarly, deletion of Ikkb prolonged survival of Ctnnb mutants ( Figure 7F ). However, consistent with a lack of Ifng induction, b-cat c.a. 
AA/AA mice and confirmed that M1-like polarization did not occur in a cell autonomous manner in IKKa mutant myeloid cells.
DISCUSSION
Cell plasticity is an important phenomenon during carcinogenesis that affects basically all cells in the tumor microenvironment (Hanahan and Weinberg, 2011) . Whereas induction of EMT altering tumor cells themselves is an essential prerequisite for invasion and metastasis, polarization of infiltrating immune cells provides the microenvironment-dominating cytokine milieu, which ultimately controls behavior of resident stromal and tumor cells. Depending on the cytokine milieu, carcinogenesis is promoted or suppressed (Grivennikov et al., 2010) . To decipher the cellular and molecular mechanisms that shape the cytokine milieu bears great therapeutic potential, because cytokine-producing immune cells are unlikely to develop resistance mechanisms in contrast to mutagenized tumor cells. Although IKKa has been suggested to control various cell autonomous tumor-promoting mechanisms in CRC (Albanese et al., 2003; Margalef et al., 2012) , here we provide evidence that IKKa comprises a central regulatory element in the suppression of M1-like myeloid cell controlled microenvironment rather than directly stimulating tumor cell proliferation. Elevated IFNg levels in Ikka AA/AA mucosa are most likely responsible for growth arrest of initiated epithelial cells. However, considering the particular intraepithelial localization of myeloid cells in b-cat c.a.
/Ikka
AA/AA mice, we cannot rule out the possibility that these cells may also participate either in extracellular killing or phagocytosis of tumor cells as it was recently demonstrated using oncogenic HRAS(G12V)-transformed cells in zebrafish larvae (Feng et al., 2010) .
Importantly, polarization of IKKa mutant myeloid cells depends on a complex interplay of IEC and infiltrating cells and is not a cell autonomously controlled process. Instead, it involves classical NF-kB-dependent secretion of chemokines in Ikka AA/AA IEC that triggers recruitment of myeloid cells, which in turn secrete cytokines that culminate in M1 polarization and fuel into a feedforward loop that drives IFNg secretion. This is further supported by the fact that administration of IL-12-neutralizing antibodies is not sufficient to block this loop and to prevent IFNg secretion (S.I.G. and F.R.G., unpublished data). However, prevention of myeloid cell infiltration and subsequent ablation of M1-like polarization can be achieved by inhibition of NF-kB activation in IEC. Considering that IKKa expression correlates with poor prognosis in human Union for International Cancer Control stage II CRC (S.I.G. and F.R.G., unpublished data), whereas IFNg upregulation is associated with improved survival (Grenz et al., 2013) , IKKa may represent a valuable therapeutic target for CRC therapy or prevention. If, however, putative IKKa inhibitors were indeed at some point considered for CRC therapy, our data imply that such compounds are required to be highly specific inhibitors of only IKKa because simultaneous overlapping IKKb inhibition would most likely prevent the beneficial effects of selective IKKa inhibition.
We recently demonstrated that, during Wnt-initiated tumorigenesis, NF-kB activation cooperates with b-catenin to control dedifferentiation of postmitotic epithelia and stem cell expansion (Schwitalla et al., 2013a) . Although in IKKa mutant IEC chemokine expression is enhanced in an NF-kB-dependent manner, we do not have any evidence that Wnt signaling is enhanced in Ikka AA/AA IEC as well. This supports the notion that IKKa is responsible for the negative regulation of a very distinct set of NF-kB target genes only (Lawrence et al., 2005; Schwitalla et al., 2013a) . Depending on the type of malignancy, IKKa can provide both tumor-promoting and tumor-suppressive mechanisms that are in most instances cell autonomous. IKKa controls expression of the inhibitor of metastasis maspin in breast and prostate cancer Tan et al., 2011) and is required for ErbB2-induced mammary tumorigenesis. In the latter case, 
AA/AA mice small intestinal mucosa 15 days after first tamoxifen administration. T cells were restimulated using PMA (20 ng/ml) and ionomycin (1 mg/ml) for 6 hr in the presence of Brefeldin A. Data are mean ± SE; n = 2. NIK-dependent IKKa activation regulates expansion of tumorinitiating cells by directly phosphorylating the cyclin-dependent kinase inhibitor p27 (Zhang et al., 2013) . Additional tumor-promoting nuclear functions of IKKa include cell cycle regulation and chromosomal accessibility by phosphorylation of histone H3, AuroraB kinase, or the nuclear corepressor SMRT, which triggers its nuclear export with HDAC3 and its degradation (Chariot, 2009 ).
In contrast, IKKa acts as a tumor suppressor in models of skin or lung SCC (Liu et al., 2008; Xiao et al., 2013) . Importantly, during development of lung SCC, IKKa kinase inactivation culminates in the recruitment of tumor-promoting inflammatory macrophages and depletion of macrophages prevents SCC formation (Xiao et al., 2013) . This is in clear contrast to our findings presented here, yet the reason for this diverse macrophage activation profile in these two different tumor entities remains currently unclear. One could envision that specific alterations in the intestinal microbiome of Ikka AA/AA mice may be involved in the tumor-suppressive M1 polarization of myeloid cells that only becomes apparent after barrier defect causing oncogene activation (Grivennikov et al., 2012) .
EXPERIMENTAL PROCEDURES
Mice Ikka AA/AA , Ikka F/F (Liu et al., 2008) , Ikkb F/F (Greten et al., 2004) , Paxian et al., 2002) , and b-cat c.a. (Schwitalla et al., 2013a) 
Protein Analysis
Isolation of enterocytes, immunoblot analysis, immune complex kinase assay, and DNA affinity precipitation assay were performed as described previously Schwitalla et al., 2013a) . 
Histological Procedures and Flow Cytometry
Standard immunohistochemical procedures were performed using the following antibodies: anti-bromodeoxyuridine (BrdU) antibody (RPN201; GE Healthcare), anti-IKKa (Abcam; ab109749; clone EPR464), CD68 (Fisher Scientific; MS-397; clone KP1), anti-c-myc (SC-788), anti-F4/80 (Caltag; MF 480043), anti-Gr-1 (eBioscience; 12-5931-85), and anti-IFNg (R&D Systems; BAF 485). For the isolation of lamina propria cells, intestines of mice were opened longitudinally, cleared of mucus, chopped into small pieces, and shook in Hank's balanced salt solution (Invitrogen) containing 30 mM EDTA (Sigma-Aldrich) at 37 C for 20 min followed by 30 s of heavy vortexing to detach the epithelial layer. The remaining tissue pieces were washed at least five times in PBS and then digested in RPMI (Invitrogen) containing 1 mg/ml collagenase I (Sigma-Aldrich) and 20 mg/ml DNase I (Sigma-Aldrich) for 90 min at 37 C while gently shaking. Liberated cells were then washed in RPMI containing 10% fetal calf serum (Biochrom) and 1% penicillin-streptomycin (Invitrogen). T cells were restimulated using phorbol myristate acetate (PMA) (20 ng/ml) and ionomycin (1 mg/ml) for 6 hr in the presence of Brefeldin A (10 mg/ml; Sigma-Aldrich). Flow cytometric analysis was performed on a Gallios flow cytometer (Beckman Coulter Genomics) or a FACSCalibur (Becton Dickinson), and results were analyzed using FlowJo software (Tree Star).
The following fluorochrome-conjugated antibodies were used: fluorescein isothiocyanate-anti-CD4 (BD-557653), phycoerythrin (PE)-anti-CD4 (BD-553651), PE-anti-CD8 (BD-550798), and PE-anti-IFNg (BD-554412).
RNA Analysis
Total RNA extraction, cDNA synthesis, real-time PCR and gene expression profiling, and GSEA were performed as described previously (Bennecke et al., 2010) . Primer sequences are available on request. In GSEA, we matched various interferon-related gene sets from GSEA Software Database (Bosco et al., 2010; Browne et al., 2001; Einav et al., 2005; Natsume et (Subramanian et al., 2005) to validate correlation between molecular pathways signatures in any phenotype of interest. For the analysis of gene sets, we modified default parameters as follows: permutation number to 1,000, collapse data set to gene symbols if ''false,'' permutation type to gene_sets, and only gene sets with the size of 1-2,000 signatures were used for analysis.
In Vitro Antigen Presentation Assay Bone-marrow-derived dendritic cells (BMDC) were differentiated from wildtype (WT) and Ikka AA/AA bone marrow in RPMI supplemented with 20 ng/ml GM-CSF for 7 days. On day 7, BMDCs were loaded with ovalbumin (0.5 mg/ml) at 37 C for 1 hr. T cells from spleens of OT II mice (Jackson Laboratories) were purified using a CD4 + CD62L + T cell isolation Kit (Miltenyi Biotech) and carboxyfluorescein succinimidyl ester (CFSE)-labeled (5 mM; 10 min; 37 C). In 96-well plates, 1 3 10 4 BMDCs were coincubated with 1 3 10 5 CFSE-labeled OT II cells for 72 hr. Subsequently, cultures were stimulated with PMA (20 ng/ml) for 6 hr, T cell proliferation was analyzed by FACS analysis on a FACS Calibur, and IFNg production was determined by ELISA.
Directed Differentiation of Naive CD4 + T Cells
Purified naive T H cells (CD4 + CD62L + ) were stimulated with anti-CD28 antibody (2 mg/ml; eBioscience) and anti-CD3e-antibody (145-2C11; 5 mg/ml; eBioscience), which had been bound to cell culture plates by anti-Syrian hamster antibody (10 mg/ml; Jackson ImmunoResearch). Cells were directed into the T H 1 line by treatment with IL-12 (2 ng/ml; R&D Systems). Anti-IL-4 antibody was added (10 mg/ml; BD Biosciences) to prevent differentiation toward the T H 2 line. Differentiation toward the T H 2 line was achieved using IL-4 (10 ng/ml; R&D Systems) in the presence of anti-IFN-g antibody (10 mg/ml; eBioscience) to suppress differentiation into T H 1 cells. Cells were collected for real-time PCR analysis, and RNA was isolated using TRI reagent (SigmaAldrich). To confirm successful differentiation, cells were tested for their capacity to produce IFN-g (T H 1) or IL-4 (T H 2). For that purpose, cells were harvested after the 3-day stimulation, washed, and incubated without stimulus but in presence of IL-2 (10 ng/ml; R&D Systems) for 3 additional days. Afterward, the cells were collected, restimulated with plate-bound anti-CD3 antibody (see above) in the presence of Brefeldin A (10 mg/ml, Sigma-Aldrich), and intracellular cytokine staining was performed.
Statistical Analysis
Data are expressed as mean ± SE. Statistical analysis methods were standard two-tailed Student's t test for two data sets and ANOVA followed by Bonferroni post hoc test for multiple data sets or log rank test for Kaplan-Meier survival graphs using Prism4 (GraphPad Software) or SPSS Statistics 21. p values % 0.05 were considered significant.
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